Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters.
The inhibitory neurotransmitter gamma-amino butyric acid (GABA) is synthesized by two isoforms of the enzyme glutamic acid decarboxylase (GAD): GAD65 and GAD67. Whereas GAD67 is constitutively active and produces >90% of GABA in the central nervous system, GAD65 is transiently activated and augments GABA levels for rapid modulation of inhibitory neurotransmission. Hydrophobic lipid modifications of the GAD65 protein target it to Golgi membranes and synaptic vesicles in neuroendocrine cells. In contrast, the GAD67 protein remains hydrophilic but has been shown to acquire membrane association by heterodimerization with GAD65. Here, we identify a second mechanism that mediates robust membrane anchoring, axonal targeting, and presynaptic clustering of GAD67 but that is independent of GAD65. This mechanism is abolished by a leucine-103 to proline mutation that changes the conformation of the N-terminal domain but does not affect the GAD65-dependent membrane anchoring of GAD67. Thus two distinct mechanisms target the constitutively active GAD67 to presynaptic clusters to facilitate accumulation of GABA for rapid delivery into synapses.
Kanaani
Jamil
J
Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
Kolibachuk
Julia
J
Martinez
Hugo
H
Baekkeskov
Steinunn
S
D000818:Animals; D001369:Axons / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D006056:Golgi Apparatus / Q000201:enzymology / Q000378:metabolism*; D049452:Green Fluorescent Proteins / Q000378:metabolism; D007527:Isoenzymes / Q000378:metabolism; D051379:Mice; D051381:Rats; D013569:Synapses / Q000378:metabolism; D009435:Synaptic Transmission; D013572:Synaptic Vesicles / Q000378:metabolism*
D007527:Isoenzymes; D049452:Green Fluorescent Proteins; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1
J Mol Biol. 1999 Apr 16;287(5):983-99
10222205
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2115-9
1549570
J Cell Biol. 1994 Jul;126(2):331-41
8034738
Diabetes. 1993 Dec;42(12):1799-808
8243826
J Physiol. 2009 May 1;587(Pt 9):1873-9
19153158
J Cell Biol. 2002 Sep 30;158(7):1229-38
12356867
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1698-703
9990087
J Cell Biol. 1994 Mar;124(6):927-34
8132714
Nat Biotechnol. 2004 Dec;22(12):1567-72
15558047
Trends Pharmacol Sci. 1998 Dec;19(12):500-5
9871412
J Biol Chem. 1998 Jun 19;273(25):15830-7
9624183
J Biol Chem. 1991 Nov 5;266(31):21257-64
1939164
Proteins. 2005 Apr 1;59(1):7-14
15690345
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11451-5
9326630
J Neurosci. 1988 Jun;8(6):2123-30
3385490
J Cell Sci. 2004 Apr 15;117(Pt 10):2001-13
15039456
Science. 1998 Nov 20;282(5393):1504-8
9822384
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4293-8
12634427
Neuron. 2007 Jun 21;54(6):889-903
17582330
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14060-5
9391152
J Biol Chem. 1999 Dec 24;274(52):37200-9
10601283
J Neurochem. 2003 Aug;86(4):879-87
12887686
Nat Rev Neurosci. 2002 Sep;3(9):715-27
12209120
Biochem Biophys Res Commun. 1996 Dec 24;229(3):891-5
8954991
Neurosci Lett. 2004 Feb 19;356(3):171-4
15036622
Neuroscience. 1999;93(4):1475-82
10501472
J Neurochem. 2006 Apr;97(2):385-96
16539672
Brain Res Mol Brain Res. 1990 Aug;8(3):193-8
2170798
Genes Brain Behav. 2003 Apr;2(2):65-70
12884963
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2832-6
7681990
Neuron. 2002 Dec 19;36(6):989-91
12495613
Brain Res. 2000 May 19;865(1):45-58
10814732
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3073-7
8464926
Mol Membr Biol. 2009 Jan;26(1):42-54
19169934
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6496-9
9177246
J Cell Biol. 1992 Jul;118(2):309-20
1321158
Nat Struct Mol Biol. 2007 Apr;14(4):280-6
17384644
J Biol Chem. 1995 Feb 3;270(5):2241-6
7836456
J Neurosci Res. 1993 Aug 1;35(5):567-76
8377226
J Cell Sci. 2008 Feb 15;121(Pt 4):437-49
18230651
J Clin Invest. 2008 Sep;118(9):3075-86
18704195
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12911-6
10536022